These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 32669844)

  • 1. A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model.
    Klapproth AP; Shevtsov M; Stangl S; Li WB; Multhoff G
    Int J Nanomedicine; 2020; 15():4677-4689. PubMed ID: 32669844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs).
    Shevtsov M; Nikolaev B; Marchenko Y; Yakovleva L; Skvortsov N; Mazur A; Tolstoy P; Ryzhov V; Multhoff G
    Int J Nanomedicine; 2018; 13():1471-1482. PubMed ID: 29559776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution and Clearance of Stable Superparamagnetic Maghemite Iron Oxide Nanoparticles in Mice Following Intraperitoneal Administration.
    Pham BTT; Colvin EK; Pham NTH; Kim BJ; Fuller ES; Moon EA; Barbey R; Yuen S; Rickman BH; Bryce NS; Bickley S; Tanudji M; Jones SK; Howell VM; Hawkett BS
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29320407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting.
    Mojica Pisciotti ML; Lima E; Vasquez Mansilla M; Tognoli VE; Troiani HE; Pasa AA; Creczynski-Pasa TB; Silva AH; Gurman P; Colombo L; Goya GF; Lamagna A; Zysler RD
    J Biomed Mater Res B Appl Biomater; 2014 May; 102(4):860-8. PubMed ID: 24458920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetically driven nanoparticles:
    De Simone M; Panetta D; Bramanti E; Giordano C; Salvatici MC; Gherardini L; Menciassi A; Burchielli S; Cinti C; Salvadori PA
    Contrast Media Mol Imaging; 2016 Nov; 11(6):561-571. PubMed ID: 28052582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-labeled superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel lymph nodes.
    Madru R; Kjellman P; Olsson F; Wingårdh K; Ingvar C; Ståhlberg F; Olsrud J; Lätt J; Fredriksson S; Knutsson L; Strand SE
    J Nucl Med; 2012 Mar; 53(3):459-63. PubMed ID: 22323777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme.
    Sun L; Joh DY; Al-Zaki A; Stangl M; Murty S; Davis JJ; Baumann BC; Alonso-Basanta M; Kaol GD; Tsourkas A; Dorsey JF
    J Biomed Nanotechnol; 2016 Feb; 12(2):347-56. PubMed ID: 27305768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum].
    Int J Nanomedicine; 2020; 15():6067. PubMed ID: 32884262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple Therapy of HER2
    Zolata H; Afarideh H; Davani FA
    Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study.
    Schlachter EK; Widmer HR; Bregy A; Lönnfors-Weitzel T; Vajtai I; Corazza N; Bernau VJ; Weitzel T; Mordasini P; Slotboom J; Herrmann G; Bogni S; Hofmann H; Frenz M; Reinert M
    Int J Nanomedicine; 2011; 6():1793-800. PubMed ID: 21980242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody.
    Nigam S; McCarl L; Kumar R; Edinger RS; Kurland BF; Anderson CJ; Panigrahy A; Kohanbash G; Edwards WB
    Mol Imaging Biol; 2020 Jun; 22(3):685-694. PubMed ID: 31529407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
    Kandasamy G; Maity D
    Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles.
    Pham TN; Lengkeek NA; Greguric I; Kim BJ; Pellegrini PA; Bickley SA; Tanudji MR; Jones SK; Hawkett BS; Pham BT
    Int J Nanomedicine; 2017; 12():899-909. PubMed ID: 28184160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of MRI quantitative susceptibility mapping of superparamagnetic iron oxide nanoparticles for hyperthermia applications in live subjects.
    Deh K; Zaman M; Vedvyas Y; Liu Z; Gillen KM; O' Malley P; Bedretdinova D; Nguyen T; Lee R; Spincemaille P; Kim J; Wang Y; Jin MM
    Sci Rep; 2020 Jan; 10(1):1171. PubMed ID: 31980695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting the Delivery of Nanoparticles to Atherosclerotic Plaques by DNA Coating.
    Zhang L; Tian XY; Chan CKW; Bai Q; Cheng CK; Chen FM; Cheung MSH; Yin B; Yang H; Yung WY; Chen Z; Ding F; Leung KC; Zhang C; Huang Y; Lau JYW; Choi CHJ
    ACS Appl Mater Interfaces; 2019 Apr; 11(15):13888-13904. PubMed ID: 30516979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma.
    Saesoo S; Sathornsumetee S; Anekwiang P; Treetidnipa C; Thuwajit P; Bunthot S; Maneeprakorn W; Maurizi L; Hofmann H; Rungsardthong RU; Saengkrit N
    Colloids Surf B Biointerfaces; 2018 Jan; 161():497-507. PubMed ID: 29128836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superparamagnetic iron-oxide nanoparticles mPEG350- and mPEG2000-coated: cell uptake and biocompatibility evaluation.
    Silva AH; Lima E; Mansilla MV; Zysler RD; Troiani H; Pisciotti MLM; Locatelli C; Benech JC; Oddone N; Zoldan VC; Winter E; Pasa AA; Creczynski-Pasa TB
    Nanomedicine; 2016 May; 12(4):909-919. PubMed ID: 26767515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative histochemistry for macrophage biodistribution on mice liver and spleen after the administration of a pharmacological-relevant dose of polyacrylic acid-coated iron oxide nanoparticles.
    Rodrigues D; Freitas M; Marisa Costa V; Arturo Lopez-Quintela M; Rivas J; Freitas P; Carvalho F; Fernandes E; Silva P
    Nanotoxicology; 2017 Mar; 11(2):256-266. PubMed ID: 28166432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues.
    Vakili-Ghartavol R; Momtazi-Borojeni AA; Vakili-Ghartavol Z; Aiyelabegan HT; Jaafari MR; Rezayat SM; Arbabi Bidgoli S
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):443-451. PubMed ID: 32024389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.